HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs
Authors:
- 6 January 2021
- journal article
- research article
- Published by Springer Nature in Science China Life Sciences
- Vol. 64 (9) , 1449-1462
Abstract
Genome-edited human induced pluripotent stem cells (iPSCs) hold great promise for therapeutic applications. However, low editing efficiency has hampered the applications of CRISPR-Cas9 technology in creating knockout and homology-directed repair (HDR)-edited iPSC lines, particularly for silent genes. This is partially due to chromatin compaction, inevitably limiting Cas9 access to the target DNA. Among the six HDAC inhibitors we examined, vorinostat, or suberoylanilide hydroxamic acid (SAHA), led to the highest HDR efficiency at both open and closed loci, with acceptable toxicity. HDAC inhibitors equally increased non-homologous end joining (NHEJ) editing efficiencies (∼50%) at both open and closed loci, due to the considerable HDAC inhibitor-mediated increase in Cas9 and sgRNA expression. However, we observed more substantial HDR efficiency improvement at closed loci relative to open chromatin (2.8 vs. 1.1-fold change). These studies provide a new strategy for HDR-editing of silent genes in iPSCs.Keywords
This publication has 60 references indexed in Scilit:
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Histone Deacetylase Inhibition Activates Transgene Expression from Integration-Defective Lentiviral Vectors in Dividing and Non-Dividing CellsHuman Gene Therapy, 2013
- The promise of induced pluripotent stem cells in research and therapyNature, 2012
- Production of De Novo Cardiomyocytes: Human Pluripotent Stem Cell Differentiation and Direct ReprogrammingCell Stem Cell, 2012
- Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciencesGenome Biology, 2010
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Chromatin Modifications and Their FunctionCell, 2007
- Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or LymphomaJournal of Clinical Oncology, 2005
- GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissuesPhysiological Genomics, 2005